ES2099827T3 - Microesferas utiles en las oclusiones vasculares terapeuticas y soluciones inyectables que contienen las mismas. - Google Patents

Microesferas utiles en las oclusiones vasculares terapeuticas y soluciones inyectables que contienen las mismas.

Info

Publication number
ES2099827T3
ES2099827T3 ES92911942T ES92911942T ES2099827T3 ES 2099827 T3 ES2099827 T3 ES 2099827T3 ES 92911942 T ES92911942 T ES 92911942T ES 92911942 T ES92911942 T ES 92911942T ES 2099827 T3 ES2099827 T3 ES 2099827T3
Authority
ES
Spain
Prior art keywords
occlusions
contain
same
injectable solutions
vascular therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92911942T
Other languages
English (en)
Spanish (es)
Inventor
Egisto Boschetti
Michel Brouard
Ludovic Drouet
Pierre Girot
Alexandre Laurent
Michel Wasser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
BioSepra SA
Original Assignee
Assistance Publique Hopitaux de Paris APHP
BioSepra SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP, BioSepra SA filed Critical Assistance Publique Hopitaux de Paris APHP
Application granted granted Critical
Publication of ES2099827T3 publication Critical patent/ES2099827T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES92911942T 1991-05-29 1992-05-20 Microesferas utiles en las oclusiones vasculares terapeuticas y soluciones inyectables que contienen las mismas. Expired - Lifetime ES2099827T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9106441A FR2676927B1 (fr) 1991-05-29 1991-05-29 Microspheres utilisables pour les occlusions vasculaires therapeutiques et solutions injectables les contenant.

Publications (1)

Publication Number Publication Date
ES2099827T3 true ES2099827T3 (es) 1997-06-01

Family

ID=9413226

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92911942T Expired - Lifetime ES2099827T3 (es) 1991-05-29 1992-05-20 Microesferas utiles en las oclusiones vasculares terapeuticas y soluciones inyectables que contienen las mismas.

Country Status (11)

Country Link
US (2) US5635215A (enExample)
EP (1) EP0588875B1 (enExample)
JP (1) JP3509858B2 (enExample)
AT (1) ATE151284T1 (enExample)
AU (1) AU661319B2 (enExample)
CA (1) CA2110290C (enExample)
DE (1) DE69218938T2 (enExample)
DK (1) DK0588875T3 (enExample)
ES (1) ES2099827T3 (enExample)
FR (1) FR2676927B1 (enExample)
WO (1) WO1992021327A1 (enExample)

Families Citing this family (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4341478C2 (de) * 1993-12-02 1998-10-08 Max Delbrueck Centrum Mittel zur Antitumortherapie
US6197324B1 (en) 1997-12-18 2001-03-06 C. R. Bard, Inc. System and methods for local delivery of an agent
US6251418B1 (en) * 1997-12-18 2001-06-26 C.R. Bard, Inc. Systems and methods for local delivery of an agent
CA2322954C (en) 1998-03-06 2011-06-07 Biosepra Inc. Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
US6660301B1 (en) 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
EP1522317A1 (en) * 1998-03-06 2005-04-13 Biosphere Medical, Inc. Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
FR2784580B1 (fr) 1998-10-16 2004-06-25 Biosepra Inc Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci
PT1163019E (pt) * 1999-03-25 2007-12-06 Metabolix Inc Dispositivos médicos e aplicações de polímeros de poli-hidroxialcanoato
US20050049178A1 (en) * 1999-07-06 2005-03-03 Oberschwabenklinik Gmbh Agent for the occlusion of blood vessels
DE29911689U1 (de) * 1999-07-06 2000-04-06 Sterk, Peter, Dr., 88212 Ravensburg Mittel für den Gefässverschluß von organischem Gewebe
US6855160B1 (en) 1999-08-04 2005-02-15 C. R. Bard, Inc. Implant and agent delivery device
EP1263802B1 (en) 2000-03-13 2005-11-23 BioCure, Inc. Hydrogel biomedical articles
DE60130544T2 (de) 2000-03-13 2008-06-26 Biocure, Inc. Embolische zusammensetzungen
US7338657B2 (en) * 2001-03-15 2008-03-04 Biosphere Medical, Inc. Injectable microspheres for tissue construction
AU2001247507A1 (en) * 2000-03-20 2001-10-03 Biosphere Medical, Inc. Injectable microspheres for tissue construction
WO2001070289A2 (en) 2000-03-20 2001-09-27 Biosphere Medical, Inc. Injectable and swellable microspheres for tissue bulking
EP1656957B1 (en) 2000-03-20 2015-06-03 Biosphere Medical, Inc. Injectable microspheres for tissue construction
US6436424B1 (en) 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
US20030212022A1 (en) * 2001-03-23 2003-11-13 Jean-Marie Vogel Compositions and methods for gene therapy
CN1430505A (zh) * 2000-03-24 2003-07-16 生物领域医疗公司 用于主动栓塞术的微球体
WO2001072280A2 (en) * 2000-03-24 2001-10-04 Biosphere Medical Inc. Microspheres for gene therapy
US7232421B1 (en) 2000-05-12 2007-06-19 C. R. Bard, Inc. Agent delivery systems
US6355275B1 (en) 2000-06-23 2002-03-12 Carbon Medical Technologies, Inc. Embolization using carbon coated microparticles
US6394965B1 (en) 2000-08-15 2002-05-28 Carbon Medical Technologies, Inc. Tissue marking using biocompatible microparticles
FR2816847B1 (fr) * 2000-11-22 2006-07-14 Assist Publ Hopitaux De Paris Biomateriaux polymeriques poreux, procede de preparation et utilisations
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
WO2002100444A1 (en) * 2001-06-08 2002-12-19 Biosphere Medical Inc. Colloidal metal labelled microparticles, their production and use
NZ532243A (en) 2001-09-12 2006-03-31 Virexx Medical Corp Vascular occlusion solid-phase agent with immobilised platelet binding agent
US7131997B2 (en) 2002-03-29 2006-11-07 Scimed Life Systems, Inc. Tissue treatment
US7094369B2 (en) 2002-03-29 2006-08-22 Scimed Life Systems, Inc. Processes for manufacturing polymeric microspheres
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7053134B2 (en) 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Forming a chemically cross-linked particle of a desired shape and diameter
US7276254B2 (en) * 2002-05-07 2007-10-02 Xerox Corporation Emulsion/aggregation polymeric microspheres for biomedical applications and methods of making same
US7838699B2 (en) * 2002-05-08 2010-11-23 Biosphere Medical Embolization using degradable crosslinked hydrogels
US7670623B2 (en) 2002-05-31 2010-03-02 Materials Modification, Inc. Hemostatic composition
AU2003240000A1 (en) 2002-06-12 2003-12-31 Boston Scientific Limited Bulking agents
US7449236B2 (en) 2002-08-09 2008-11-11 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7112620B2 (en) * 2002-10-18 2006-09-26 Albright Robert L Hemocompatible polymer systems & related methods
US20040168245A1 (en) * 2002-10-18 2004-09-02 Goodwin Edward L. Washable, protective hip pad construction
US7588825B2 (en) 2002-10-23 2009-09-15 Boston Scientific Scimed, Inc. Embolic compositions
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US20060069168A1 (en) * 2002-10-29 2006-03-30 Norikazu Tabata Vascular embolization material
JP4686970B2 (ja) * 2002-10-29 2011-05-25 東レ株式会社 血管塞栓材料
EP1578455A4 (en) * 2002-11-04 2008-12-31 Biosphere Medical Inc RADIOISOTOP ASSOCIATED POLYMEREHYDROGEL MICRO BEADS AND METHOD FOR THE PRODUCTION AND USE THEREOF
US7560160B2 (en) * 2002-11-25 2009-07-14 Materials Modification, Inc. Multifunctional particulate material, fluid, and composition
US7007972B1 (en) 2003-03-10 2006-03-07 Materials Modification, Inc. Method and airbag inflation apparatus employing magnetic fluid
JP2004313759A (ja) * 2003-03-31 2004-11-11 Toray Ind Inc 血管塞栓材料
DK1638615T3 (en) 2003-05-08 2015-01-12 Tepha Inc MEDICAL POLYHYDROXYALKANOATE TEXTILES AND FIBERS
US6982501B1 (en) 2003-05-19 2006-01-03 Materials Modification, Inc. Magnetic fluid power generator device and method for generating power
ES2395077T3 (es) * 2003-07-08 2013-02-08 Tepha, Inc. Matrices poli-4-hidroxibutirato para una administración prolongada de medicamentos
US7200956B1 (en) 2003-07-23 2007-04-10 Materials Modification, Inc. Magnetic fluid cushioning device for a footwear or shoe
JP2007503221A (ja) * 2003-08-22 2007-02-22 テファ， インコーポレイテッド ポリヒドロキシアルカノエート神経再生デバイス
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7448389B1 (en) 2003-10-10 2008-11-11 Materials Modification, Inc. Method and kit for inducing hypoxia in tumors through the use of a magnetic fluid
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
WO2005107747A2 (en) * 2004-05-06 2005-11-17 Bioresponse, Llc Diindolymethane formulations for the treatment of leiomyomas
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
PT1778305E (pt) * 2004-08-03 2010-07-27 Tepha Inc Suturas de poli-hidroxialcanoato que n†o se enrolam
EP1796737B1 (en) * 2004-09-24 2018-10-24 Biosphere Medical, Inc. Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, as well as methods of use thereof
US20060073208A1 (en) * 2004-10-01 2006-04-06 Allergan, Inc. Cosmetic neurotoxin compositions and methods
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
BRPI0518383A2 (pt) 2004-10-25 2008-11-18 Polyzenix Gmbh partÍculas polimÉricas carregÁveis para aplicaÇÕes terepÊuticas e/ou diagnàstico e mÉtodos para preparar e usar as mesmas
US8425550B2 (en) 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
CA2593084C (en) 2004-12-30 2014-03-18 Bioresponse, Llc Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions
US20080213593A1 (en) * 2005-01-21 2008-09-04 President And Fellows Of Harvard College Systems And Methods For Forming Fluidic Droplets Encapsulated In Particles Such As Colloidal Particles
WO2006081517A2 (en) * 2005-01-28 2006-08-03 Tepha, Inc. Embolization using poly-4-hydroxybutyrate particles
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
CA2607228C (en) 2005-05-09 2014-09-16 Biosphere Medical S.A. Compositions and methods using microspheres and non-ionic contrast agents
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US8007509B2 (en) 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US8152839B2 (en) 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US7501179B2 (en) 2005-12-21 2009-03-10 Boston Scientific Scimed, Inc. Block copolymer particles
US20080033366A1 (en) * 2006-01-30 2008-02-07 Surgica Corporation Compressible intravascular embolization particles and related methods and delivery systems
EP1986706B1 (en) * 2006-01-30 2011-08-17 Biosphere Medical, Inc. Porous intravascular embolization particles and methods of making them
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
WO2008057253A2 (en) 2006-10-27 2008-05-15 Bioresponse, L.L.C. Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
US8414927B2 (en) 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
US7943683B2 (en) * 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
WO2008134580A2 (en) * 2007-04-27 2008-11-06 Amylin Pharmaceuticals, Inc. Drug delivery device
CA2709581C (en) * 2007-12-17 2013-06-11 Anna Love Soft tissue filler
WO2010062678A2 (en) * 2008-10-30 2010-06-03 David Liu Micro-spherical porous biocompatible scaffolds and methods and apparatus for fabricating same
WO2010062734A1 (en) * 2008-11-03 2010-06-03 University Of Maryland, Baltimore Blood coagulation inducing polymer hydrogel
KR101632480B1 (ko) 2009-10-06 2016-06-21 리전츠 오브 더 유니버스티 오브 미네소타 생분해성 색전술용 미소구체
EP2351779B1 (en) * 2010-01-27 2019-04-24 Biosphere Medical, Inc. Microspheres and method of making the microspheres
CA2831414C (en) * 2011-03-30 2016-03-22 Toray Industries, Inc. Biodegradable particle, vascular embolization material and method for producing biodegradable particles
EP3295961B1 (en) * 2012-05-24 2020-04-08 Biosphere Medical Inc. Biomaterials suitable for use as drug eluting, magnetic resonance imaging detectable implants for vascular occlusion
US8936795B2 (en) 2012-12-19 2015-01-20 Regents Of The University Of Minnesota Liquid embolic material including carboxymethyl chitosan crosslinked with carboxymethyl cellulose
US9687573B2 (en) 2013-03-13 2017-06-27 Biosphere Medical, Inc. Compositions and associated methods for radioisotope-binding microparticles
WO2015042170A1 (en) 2013-09-17 2015-03-26 Wayne State University Compositions and uses of combinations of dim-related indoles and selected anti-androgen compounds
US9546236B2 (en) 2013-09-19 2017-01-17 Terumo Corporation Polymer particles
US9408916B2 (en) 2013-09-19 2016-08-09 Microvention, Inc. Polymer films
CN105916495B (zh) 2013-11-08 2019-11-12 泰尔茂株式会社 聚合物颗粒
WO2016025329A1 (en) 2014-08-15 2016-02-18 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
WO2016094669A1 (en) 2014-12-11 2016-06-16 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
ES2834737T3 (es) 2015-01-12 2021-06-18 Biosphere Medical Inc Monómeros, polímeros y microesferas radiopacas y métodos relacionados con los mismos
WO2016154592A1 (en) 2015-03-26 2016-09-29 Microvention, Inc. Embiolic particles
US10071181B1 (en) 2015-04-17 2018-09-11 Teleflex Innovations S.À.R.L. Resorbable embolization spheres
US20190070332A1 (en) 2016-03-14 2019-03-07 Biocompatibles Uk Limited Oily compositions
US10182979B2 (en) 2016-03-22 2019-01-22 Regents Of The University Of Minnesota Biodegradable microspheres
CA3038719C (en) 2016-09-28 2020-04-21 Terumo Corporation Polymer particles
KR20220081358A (ko) * 2019-10-07 2022-06-15 게르브 비분해성 색전술 미소구체
EP4041319A1 (fr) * 2019-10-07 2022-08-17 Guerbet Microsphere d'embolisation non degradable radio-opaque
CN116672489B (zh) * 2023-05-30 2025-12-05 河南驼人贝斯特医疗器械有限公司 一种彩色栓塞微球及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797485A (en) * 1971-03-26 1974-03-19 Alza Corp Novel drug delivery device for administering drug into blood circulation in blood vessel
US4413070A (en) * 1981-03-30 1983-11-01 California Institute Of Technology Polyacrolein microspheres
US4622362A (en) * 1981-03-30 1986-11-11 California Institute Of Technology Polyacrolein microspheres
EP0086627B1 (en) * 1982-02-12 1985-08-28 Unitika Ltd. Anti-cancer device
JPS61293911A (ja) * 1985-06-24 1986-12-24 Teisan Seiyaku Kk 徐放化製剤
JPS62169723A (ja) * 1986-01-22 1987-07-25 Teisan Seiyaku Kk 徐放化製剤

Also Published As

Publication number Publication date
WO1992021327A1 (en) 1992-12-10
ATE151284T1 (de) 1997-04-15
EP0588875A1 (en) 1994-03-30
US5648100A (en) 1997-07-15
FR2676927B1 (fr) 1995-06-23
FR2676927A1 (fr) 1992-12-04
AU2016892A (en) 1993-01-08
US5635215A (en) 1997-06-03
JP3509858B2 (ja) 2004-03-22
EP0588875A4 (enExample) 1994-08-03
EP0588875B1 (en) 1997-04-09
DE69218938T2 (de) 1997-07-31
DK0588875T3 (da) 1997-04-28
AU661319B2 (en) 1995-07-20
CA2110290A1 (en) 1992-12-10
CA2110290C (en) 2002-02-05
JPH06508139A (ja) 1994-09-14
DE69218938D1 (de) 1997-05-15

Similar Documents

Publication Publication Date Title
ES2099827T3 (es) Microesferas utiles en las oclusiones vasculares terapeuticas y soluciones inyectables que contienen las mismas.
ES2134277T3 (es) Producto de organo-aluminoxi y uso.
AR002932A1 (es) Solucion acuosa de interferon
DE3866938D1 (de) Steroid-5-alpha-reduktase-inhibitoren.
IL71621A0 (en) Use of alpha factor sequences in yeast expression systems
ES2049270T3 (es) Pelicula de baja emisividad para la reduccion de la carga termica en automoviles.
FI894541A0 (fi) Aids-laekemedel baserade pao hiv-proteasinhibitorer.
DE68901538D1 (de) Rostfreier duplexstahl mit hohem mangangehalt.
DK202389A (da) Engangssproejte med envejssystem
KR970702733A (ko) 활성물질의 방출 조절용 콜라겐 제제(collagen preparation the controlled release of active substances)
ES2051266T3 (es) Adhesivo de uso general alcalino, acuoso, a base de polimetacrilato.
NO895327D0 (no) Staal med hoey styrke.
EP0699070A4 (en) AURINTRICARBONIC ACID FRACTIONS AND ANALOGA WITH ANTIANGIOGENIC ACTIVITY AND METHOD FOR ITS USE
DE68908113D1 (de) Head-up anzeigesysteme.
ES2020167A4 (es) Tubo elastico con amortiguamiento hidraulico de la elasticidad radial y desacoplamiento en rigidez.
FI904965A0 (fi) Nya alfa-glukosidasinhibitorer.
BR0012006A (pt) Método para evitar inflamações, doenças autoimunes e crescimento de tumor, e, uso de substâncias que suprimem a ativação mediada por ltbr
ZA843060B (en) Use of alpha factor sequences in yeast expression systems
FI883943A0 (fi) Modifierade plasminogen-aktivatorer.
ES1008874U (es) Perfil de apoyo de goma para objetos de adorno de vidrio y similares.
FI894653A7 (fi) Stabiileja oksapeneemi-3-karboksyylihappoja ja niiden käyttö b-laktamaasin estäjinä
AT399706B (de) Fass
FI952018L (fi) BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
AU2722184A (en) Use of alpha sequences in yeast expression systems
NO883124D0 (no) Hjoernereflektor til bruk i en radarballong.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 588875

Country of ref document: ES